Please enable JavaScript to continue using this application.

Compare $CLNN vs $RNXT | Chartloom

Compare

$CLNN vs $RNXT

Clene Inc · RenovoRx Inc

CLNN

Clene Inc

RNXT

RenovoRx Inc

Compare $CLNN vs $RNXT

Comparing Clene Inc and RenovoRx Inc

CLNNClene Inc

RNXTRenovoRx Inc

CLNNClene Inc

Market cap

$49M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

176.51x

Rev growth (TTM)

-31.1%

YTD performance

-33.1%

52W performance

-59.0%

FCF yield

-32.3%

RNXTRenovoRx Inc

Market cap

$58M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

8.70x

Rev growth (TTM)

198.5%

YTD performance

53.3%

52W performance

5.8%

FCF yield

-20.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLNN

RNXT

Detailed metrics comparison

CLNN

Clene Inc

RNXT

RenovoRx Inc

Market Cap

CLNN$49M

RNXT$58M

Enterprise Value

CLNN$58M

RNXT$48M

Price

CLNN$3.86

RNXT$1.28

P/E Ratio

CLNNN/A

RNXTN/A

P/S Ratio

CLNN250.41x

RNXT29.18x

EV/Sales

CLNN296.36x

RNXT24.39x

EV/EBITDA

CLNN0.00x

RNXT0.00x

P/B Ratio

CLNN13.60x

RNXT7.94x

P/FCF Ratio

CLNNN/A

RNXTN/A

EV/FCF

CLNN-3.66x

RNXT-4.04x

PEG Ratio

CLNNN/A

RNXTN/A

Forward P/E (NTM)

CLNNN/A

RNXTN/A

Forward P/S (NTM)

CLNN176.51x

RNXT8.70x

Revenue (TTM)

CLNN$197K

RNXT$2M

Revenue Growth (YoY)

CLNN-31.1%

RNXT198.5%

Forward Rev Growth

CLNN10485.4%

RNXT195.2%

Gross Margin (TTM)

CLNN70.1%

RNXT84.4%

Operating Margin (TTM)

CLNN0.0%

RNXT0.0%

EBITDA Margin (TTM)

CLNN-9704.6%

RNXT-684.9%

Net Margin (TTM)

CLNN-20059.9%

RNXT-621.7%

FCF Margin (TTM)

CLNN-8094.9%

RNXT-604.1%

Net Income (TTM)

CLNN$-40M

RNXT$-12M

FCF (TTM)

CLNN$-16M

RNXT$-12M

EPS (TTM)

CLNN-$3.19

RNXT-$0.26

ROE (TTM)

CLNN-32223.0%

RNXT-14563.0%

ROA (TTM)

CLNN-18564.0%

RNXT-10984.0%

ROIC (TTM)

CLNN-11721.0%

RNXT-14563.0%

Cash

CLNN$10M

RNXT$9M

Debt

CLNN$19M

RNXT$0

Net Cash/Debt

CLNN$-9M

RNXT$9M

Current Ratio (TTM)

CLNN3.07x

RNXT5.74x

Quick Ratio (TTM)

CLNN2.91x

RNXT5.37x

Debt/Equity (TTM)

CLNN6.36x

RNXT0.00x

Debt/Assets (TTM)

CLNN0.0%

RNXT0.0%

Interest Coverage (TTM)

CLNNN/A

RNXTN/A

Net Debt/EBITDA (TTM)

CLNN0.00x

RNXT0.00x

Beta

CLNN1.06

RNXT1.07

52W Performance

CLNN-59.0%

RNXT5.8%

YTD Performance

CLNN-33.1%

RNXT53.3%

% from 52W High

CLNN-71.4%

RNXT-50.6%

% from 52W Low

CLNN18.8%

RNXT82.7%

Asset Turnover (TTM)

CLNN0.01x

RNXT0.18x

FCF Yield (TTM)

CLNN-32.3%

RNXT-20.7%

Earnings Yield (TTM)

CLNN-80.1%

RNXT-21.3%

Dividend Yield (TTM)

CLNNN/A

RNXTN/A

Rule of 40

CLNN-8,126.0

RNXT-405.6

EV/GP/RG

CLNN10.10

RNXT0.12

Ticker research

View CLNN research View RNXT research

Metric	CLNN Clene Inc	RNXT RenovoRx Inc
Market & Valuation
Market Cap	$49M	$58M
Enterprise Value	$58M	$48M
Price	$3.86	$1.28
P/E Ratio	N/A	N/A
P/S Ratio	250.41x	29.18x
EV/Sales	296.36x	24.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.60x	7.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.66x	-4.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	176.51x	8.70x
Revenue & Growth
Revenue (TTM)	$197K	$2M
Revenue Growth (YoY)	-31.1%	198.5%
Forward Rev Growth	10485.4%	195.2%
Profitability
Gross Margin (TTM)	70.1%	84.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-9704.6%	-684.9%
Net Margin (TTM)	-20059.9%	-621.7%
FCF Margin (TTM)	-8094.9%	-604.1%
Net Income (TTM)	$-40M	$-12M
FCF (TTM)	$-16M	$-12M
EPS (TTM)	-$3.19	-$0.26
ROE (TTM)	-32223.0%	-14563.0%
ROA (TTM)	-18564.0%	-10984.0%
ROIC (TTM)	-11721.0%	-14563.0%
Financial Health
Cash	$10M	$9M
Debt	$19M	$0
Net Cash/Debt	$-9M	$9M
Current Ratio (TTM)	3.07x	5.74x
Quick Ratio (TTM)	2.91x	5.37x
Debt/Equity (TTM)	6.36x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.06	1.07
52W Performance	-59.0%	5.8%
YTD Performance	-33.1%	53.3%
% from 52W High	-71.4%	-50.6%
% from 52W Low	18.8%	82.7%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.18x
FCF Yield (TTM)	-32.3%	-20.7%
Earnings Yield (TTM)	-80.1%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,126.0	-405.6
EV/GP/RG	10.10	0.12
Ticker research	View CLNN research	View RNXT research

Valuation

P/S Ratio

RNXT

29.18x

CLNN

250.41x

EV/FCF

RNXT

-4.04x

CLNN

-3.66x

Growth & revenue

Revenue Growth TTM

RNXT

198.5%

CLNN

-31.1%

Forward Revenue Growth

CLNN

10485.4%

RNXT

195.2%

Profitability & performance

Gross Margin

RNXT

84.4%

CLNN

70.1%

ROE

RNXT

-14563.0%

CLNN

-32223.0%

FCF Yield %

RNXT

-20.7%

CLNN

-32.3%

52-Week Performance

RNXT

5.8%

CLNN

-59.0%

Detailed metrics comparison

CLNN

Clene Inc

RNXT

RenovoRx Inc

Market Cap

CLNN$49M

RNXT$58M

Enterprise Value

CLNN$58M

RNXT$48M

Price

CLNN$3.86

RNXT$1.28

P/E Ratio

CLNNN/A

RNXTN/A

P/S Ratio

CLNN250.41x

RNXT29.18x

EV/Sales

CLNN296.36x

RNXT24.39x

EV/EBITDA

CLNN0.00x

RNXT0.00x

P/B Ratio

CLNN13.60x

RNXT7.94x

P/FCF Ratio

CLNNN/A

RNXTN/A

EV/FCF

CLNN-3.66x

RNXT-4.04x

PEG Ratio

CLNNN/A

RNXTN/A

Forward P/E (NTM)

CLNNN/A

RNXTN/A

Forward P/S (NTM)

CLNN176.51x

RNXT8.70x

Revenue (TTM)

CLNN$197K

RNXT$2M

Revenue Growth (YoY)

CLNN-31.1%

RNXT198.5%

Forward Rev Growth

CLNN10485.4%

RNXT195.2%

Gross Margin (TTM)

CLNN70.1%

RNXT84.4%

Operating Margin (TTM)

CLNN0.0%

RNXT0.0%

EBITDA Margin (TTM)

CLNN-9704.6%

RNXT-684.9%

Net Margin (TTM)

CLNN-20059.9%

RNXT-621.7%

FCF Margin (TTM)

CLNN-8094.9%

RNXT-604.1%

Net Income (TTM)

CLNN$-40M

RNXT$-12M

FCF (TTM)

CLNN$-16M

RNXT$-12M

EPS (TTM)

CLNN-$3.19

RNXT-$0.26

ROE (TTM)

CLNN-32223.0%

RNXT-14563.0%

ROA (TTM)

CLNN-18564.0%

RNXT-10984.0%

ROIC (TTM)

CLNN-11721.0%

RNXT-14563.0%

Cash

CLNN$10M

RNXT$9M

Debt

CLNN$19M

RNXT$0

Net Cash/Debt

CLNN$-9M

RNXT$9M

Current Ratio (TTM)

CLNN3.07x

RNXT5.74x

Quick Ratio (TTM)

CLNN2.91x

RNXT5.37x

Debt/Equity (TTM)

CLNN6.36x

RNXT0.00x

Debt/Assets (TTM)

CLNN0.0%

RNXT0.0%

Interest Coverage (TTM)

CLNNN/A

RNXTN/A

Net Debt/EBITDA (TTM)

CLNN0.00x

RNXT0.00x

Beta

CLNN1.06

RNXT1.07

52W Performance

CLNN-59.0%

RNXT5.8%

YTD Performance

CLNN-33.1%

RNXT53.3%

% from 52W High

CLNN-71.4%

RNXT-50.6%

% from 52W Low

CLNN18.8%

RNXT82.7%

Asset Turnover (TTM)

CLNN0.01x

RNXT0.18x

FCF Yield (TTM)

CLNN-32.3%

RNXT-20.7%

Earnings Yield (TTM)

CLNN-80.1%

RNXT-21.3%

Dividend Yield (TTM)

CLNNN/A

RNXTN/A

Rule of 40

CLNN-8,126.0

RNXT-405.6

EV/GP/RG

CLNN10.10

RNXT0.12

Ticker research

View CLNN research View RNXT research

Metric	CLNN Clene Inc	RNXT RenovoRx Inc
Market & Valuation
Market Cap	$49M	$58M
Enterprise Value	$58M	$48M
Price	$3.86	$1.28
P/E Ratio	N/A	N/A
P/S Ratio	250.41x	29.18x
EV/Sales	296.36x	24.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.60x	7.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.66x	-4.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	176.51x	8.70x
Revenue & Growth
Revenue (TTM)	$197K	$2M
Revenue Growth (YoY)	-31.1%	198.5%
Forward Rev Growth	10485.4%	195.2%
Profitability
Gross Margin (TTM)	70.1%	84.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-9704.6%	-684.9%
Net Margin (TTM)	-20059.9%	-621.7%
FCF Margin (TTM)	-8094.9%	-604.1%
Net Income (TTM)	$-40M	$-12M
FCF (TTM)	$-16M	$-12M
EPS (TTM)	-$3.19	-$0.26
ROE (TTM)	-32223.0%	-14563.0%
ROA (TTM)	-18564.0%	-10984.0%
ROIC (TTM)	-11721.0%	-14563.0%
Financial Health
Cash	$10M	$9M
Debt	$19M	$0
Net Cash/Debt	$-9M	$9M
Current Ratio (TTM)	3.07x	5.74x
Quick Ratio (TTM)	2.91x	5.37x
Debt/Equity (TTM)	6.36x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.06	1.07
52W Performance	-59.0%	5.8%
YTD Performance	-33.1%	53.3%
% from 52W High	-71.4%	-50.6%
% from 52W Low	18.8%	82.7%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.18x
FCF Yield (TTM)	-32.3%	-20.7%
Earnings Yield (TTM)	-80.1%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8,126.0	-405.6
EV/GP/RG	10.10	0.12
Ticker research	View CLNN research	View RNXT research